ADGM
Income statement / Annual
Last year (2025), Adagio Medical Holdings Inc.'s total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2025, Adagio Medical Holdings Inc.'s net income was -$25.08 M.
See Adagio Medical Holdings Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$0.00 |
$269.00 K |
$300.00 K |
$189.00 K |
$270.00 K |
$0.00 |
| Cost of Revenue |
$1.65 M
|
$1.94 M
|
$1.31 M
|
$875.00 K
|
$1.16 M
|
$0.00
|
| Gross Profit |
-$1.65 M
|
-$1.67 M
|
-$1.01 M
|
-$686.00 K
|
-$888.00 K
|
$0.00
|
| Gross Profit Ratio |
0
|
-6.2
|
-3.35
|
-3.63
|
-3.29
|
0
|
| Research and Development Expenses |
$10.64 M
|
$4.63 M
|
$15.40 M
|
$17.86 M
|
$15.36 M
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$4.75 M
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$6.78 M
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$9.60 M
|
$6.98 M
|
$11.54 M
|
$5.37 M
|
$4.40 M
|
$13.54 K
|
| Other Expenses |
$0.00
|
$49.20 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$20.24 M
|
$60.81 M
|
$26.94 M
|
$23.23 M
|
$19.76 M
|
$13.54 K
|
| Cost And Expenses |
$21.89 M
|
$62.75 M
|
$28.24 M
|
$24.10 M
|
$20.92 M
|
$13.54 K
|
| Interest Income |
$477.00 K
|
$423.00 K
|
$3.00 K
|
$39.00 K
|
$3.00 K
|
$0.00
|
| Interest Expense |
$2.91 M
|
-$1.10 M
|
$1.66 M
|
$137.00 K
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$970.00 K
|
-$7.61 M
|
$532.00 K
|
$495.00 K
|
$336.00 K
|
$0.00
|
| EBITDA |
-$20.92 M |
-$62.48 M |
-$27.41 M |
-$23.04 M |
-$19.60 M |
-$13.54 K |
| EBITDA Ratio |
0
|
-232.27
|
-91.37
|
-121.91
|
-72.6
|
0
|
| Operating Income Ratio |
0
|
-232.27
|
-93.14
|
-126.52
|
-76.46
|
0
|
| Total Other Income/Expenses Net |
-$3.19 M
|
$8.72 M
|
-$10.20 M
|
$240.00 K
|
$707.00 K
|
$0.00
|
| Income Before Tax |
-$25.08 M
|
-$53.76 M
|
-$38.15 M
|
-$23.67 M
|
-$19.94 M
|
-$13.54 K
|
| Income Before Tax Ratio |
0
|
-199.86
|
-127.15
|
-125.25
|
-73.84
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$25.08 M
|
-$53.76 M
|
-$38.15 M
|
-$23.67 M
|
-$19.94 M
|
-$13.54 K
|
| Net Income Ratio |
0
|
-199.86
|
-127.15
|
-125.25
|
-73.84
|
0
|
| EPS |
-1.51 |
-3.54 |
-4.86 |
0.0556 |
-0.34 |
-0.0007 |
| EPS Diluted |
-1.51 |
-3.54 |
-4.86 |
0.0556 |
-0.34 |
-0.0007 |
| Weighted Average Shares Out |
$16.58 M
|
$15.20 M
|
$7.86 M
|
$19.19 M
|
$19.19 M
|
$19.19 M
|
| Weighted Average Shares Out Diluted |
$16.58 M
|
$15.20 M
|
$7.86 M
|
$19.19 M
|
$19.19 M
|
$19.19 M
|
| Link |
|
|
|
|
|
|
